Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Evguenia Svarovskaia
Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections
Gastroenterology
Hepatology
Gastroenterology
Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
JAMA - Journal of the American Medical Association
Medicine
Related publications
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial
Gastroenterology
Hepatology
Gastroenterology
Sofosbuvir-Velpatasvir-Voxilaprevir With or Without Ribavirin in Direct-Acting Antiviral-Experienced Patients With Genotype 1 Hepatitis C Virus
Hepatology
Medicine
Hepatology
Effectiveness of 8- Or 12-Weeks of Ledipasvir and Sofosbuvir in Real-World Treatment-Naïve, Genotype 1 Hepatitis C Infected Patients
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
A1-2: Cost-Effectiveness of Interleukin 28B Genotype-Guided Protease Inhibitor Therapy in Treatment-Naive Patients With Hepatitis C Virus Genotype 2 or 3
Clinical Medicine and Research
Medicine
Home Care
Community
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy
Gastroenterology
Hepatology
Gastroenterology
Combinations of Cyclophilin Inhibitor NIM811 With Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of Resistance
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In VitroAntiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
High Efficacy of Sofosbuvir/Velpatasvir and Impact of Baseline Resistance-Associated Substitutions in Hepatitis C Genotype 3 Infection
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in Treatment-Naïve Hepatitis C Virus Genotype 1-Infected Patients Without Cirrhosis Treated With a Simeprevir/Sofosbuvir/Ledipasvir Regimen
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
